Moderna’s Bancel Dismisses GSK And Sanofi Challenge In mRNA Vaccines
New Entrants Will Find “It’s Much Harder Than They Think”
Under pressure to show Moderna can grow the company’s mRNA vaccines portfolio beyond COVID-19, CEO Stéphane Bancel has talked down his rivals in the field.
